drugset / Trial / NCT04263922
Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3
Phase 4
Unknown
466 enrolled
The First Affiliated Hospital of Dalian Medical University
Huazhong University of Science and Technology · collabLinkDoc Technology (Beijing) Co. Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicentre prospective, randomized, double-blind and imitation, positive-drug parallel controlled clinical trail. The objective of this study is to evaluate the efficacy and safety of Huaiqihuang Granule in patients with CKD stage 3 primary glomerulonephritis.
Timeline
- Start
- 2020-06-30
- Primary completion
- 2025-10-31
- Completion
- 2026-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huaiqihuang granules | Traditional medicine (herbal / TCM) | 2 unknown | Oral |
| Comparator | Valsartan capsule | Unknown | 80 mg | Oral |